BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21693656)

  • 1. BARD1 expression predicts outcome in colon cancer.
    Sporn JC; Hothorn T; Jung B
    Clin Cancer Res; 2011 Aug; 17(16):5451-62. PubMed ID: 21693656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer.
    Ozden O; Bishehsari F; Bauer J; Park SH; Jana A; Baik SH; Sporn JC; Staudacher JJ; Yazici C; Krett N; Jung B
    Sci Rep; 2016 May; 6():26273. PubMed ID: 27197561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BARD1: an independent predictor of survival in non-small cell lung cancer.
    Zhang YQ; Bianco A; Malkinson AM; Leoni VP; Frau G; De Rosa N; André PA; Versace R; Boulvain M; Laurent GJ; Atzori L; Irminger-Finger I
    Int J Cancer; 2012 Jul; 131(1):83-94. PubMed ID: 21815143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 and BARD1 colocalize mainly in the cytoplasm of breast cancer tumors, and their isoforms show differential expression.
    Wiener D; Gajardo-Meneses P; Ortega-Hernández V; Herrera-Cares C; Díaz S; Fernández W; Cornejo V; Gamboa J; Tapia T; Alvarez C; Carvallo P
    Breast Cancer Res Treat; 2015 Oct; 153(3):669-78. PubMed ID: 26395808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome.
    Zhang YQ; Pilyugin M; Kuester D; Leoni VP; Li L; Casula G; Zorcolo L; Schneider-Stock R; Atzori L; Irminger-Finger I
    Br J Cancer; 2012 Aug; 107(4):675-83. PubMed ID: 22814582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic BARD1 isoforms expressed in gynecological cancers.
    Li L; Ryser S; Dizin E; Pils D; Krainer M; Jefford CE; Bertoni F; Zeillinger R; Irminger-Finger I
    Cancer Res; 2007 Dec; 67(24):11876-85. PubMed ID: 18089818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of BARD1 β Isoform in Selected Pediatric Tumors.
    Jasiak A; Krawczyńska N; Iliszko M; Czarnota K; Buczkowski K; Stefanowicz J; Adamkiewicz-Drożyńska E; Cichosz G; Iżycka-Świeszewska E
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33530592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BARD1 splice variants display mislocalization in breast cancer cells and can alter the apoptotic response to cisplatin.
    Marzec KA; Martino-Echarri E; Irminger-Finger I; Henderson BR
    Cancer Lett; 2016 Oct; 381(1):149-55. PubMed ID: 27477900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
    Wu JY; Vlastos AT; Pelte MF; Caligo MA; Bianco A; Krause KH; Laurent GJ; Irminger-Finger I
    Int J Cancer; 2006 Mar; 118(5):1215-26. PubMed ID: 16152612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of BARD1 splice-isoforms involved in human trophoblast invasion.
    Li L; Cohen M; Wu J; Sow MH; Nikolic B; Bischof P; Irminger-Finger I
    Int J Biochem Cell Biol; 2007; 39(9):1659-72. PubMed ID: 17556008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BARD1 mystery: tumor suppressors are cancer susceptibility genes.
    Hawsawi YM; Shams A; Theyab A; Abdali WA; Hussien NA; Alatwi HE; Alzahrani OR; Oyouni AAA; Babalghith AO; Alreshidi M
    BMC Cancer; 2022 Jun; 22(1):599. PubMed ID: 35650591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Expression of
    McDougall LI; Powell RM; Ratajska M; Lynch-Sutherland CF; Hossain SM; Wiggins GAR; Harazin-Lechowska A; Cybulska-Stopa B; Motwani J; Macaulay EC; Reid G; Walker LC; Ryś J; Eccles MR
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33672422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA and microRNAs might act in regulating the expression of BARD1 mRNAs.
    Pilyugin M; Irminger-Finger I
    Int J Biochem Cell Biol; 2014 Sep; 54():356-67. PubMed ID: 25008968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms.
    Ratajska M; Matusiak M; Kuzniacka A; Wasag B; Brozek I; Biernat W; Koczkowska M; Debniak J; Sniadecki M; Kozlowski P; Klonowska K; Pilyugin M; Wydra D; Laurent G; Limon J; Irminger-Finger I
    Oncol Rep; 2015 Nov; 34(5):2609-17. PubMed ID: 26329992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel alternatively spliced BRCA1-associated RING domain (BARD1) messenger RNAs in human peripheral blood lymphocytes and in sporadic breast cancer tissues.
    Lombardi G; Falaschi E; Di Cristofano C; Naccarato AG; Sensi E; Aretini P; Roncella M; Bevilacqua G; Caligo MA
    Genes Chromosomes Cancer; 2007 Sep; 46(9):791-5. PubMed ID: 17497650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics Analysis of Expression and Alterations of BARD1 in Breast Cancer.
    Chen YZ; Zuo D; Ren HL; Fan SJ; Ying G
    Technol Cancer Res Treat; 2019; 18():1533033819892260. PubMed ID: 31808361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA assay identifies a previous misclassification of BARD1 c.1977A>G variant.
    Rofes P; Pineda M; Feliubadaló L; Menéndez M; de Cid R; Gómez C; Montes E; Capellá G; Brunet J; Del Valle J; Lázaro C
    Sci Rep; 2021 Nov; 11(1):22948. PubMed ID: 34824355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling.
    Liao Y; Yuan S; Chen X; Zhu P; Li J; Qin L; Liao W
    Sci Rep; 2017 Aug; 7(1):7649. PubMed ID: 28794477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Analysis of BARD1 Missense Variants in Homology-Directed Repair of DNA Double Strand Breaks.
    Lee C; Banerjee T; Gillespie J; Ceravolo A; Parvinsmith MR; Starita LM; Fields S; Toland AE; Parvin JD
    Hum Mutat; 2015 Dec; 36(12):1205-14. PubMed ID: 26350354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.
    Dizin E; Irminger-Finger I
    Int J Biochem Cell Biol; 2010 May; 42(5):693-700. PubMed ID: 20060929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.